KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Loans - Loss Allowance (2017 - 2025)

Historic Loans - Loss Allowance for Omega Healthcare Investors (OHI) over the last 10 years, with Q4 2025 value amounting to $100.3 million.

  • Omega Healthcare Investors' Loans - Loss Allowance fell 1835.01% to $100.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $100.3 million, marking a year-over-year decrease of 1835.01%. This contributed to the annual value of $100.3 million for FY2025, which is 1835.01% down from last year.
  • Omega Healthcare Investors' Loans - Loss Allowance amounted to $100.3 million in Q4 2025, which was down 1835.01% from $101.8 million recorded in Q3 2025.
  • Omega Healthcare Investors' 5-year Loans - Loss Allowance high stood at $209.5 million for Q1 2023, and its period low was $35.5 million during Q2 2021.
  • For the 5-year period, Omega Healthcare Investors' Loans - Loss Allowance averaged around $112.7 million, with its median value being $107.1 million (2025).
  • In the last 5 years, Omega Healthcare Investors' Loans - Loss Allowance soared by 18251.22% in 2023 and then plummeted by 4227.21% in 2024.
  • Over the past 5 years, Omega Healthcare Investors' Loans - Loss Allowance (Quarter) stood at $82.6 million in 2021, then rose by 22.75% to $101.4 million in 2022, then rose by 20.0% to $121.6 million in 2023, then grew by 0.96% to $122.8 million in 2024, then decreased by 18.35% to $100.3 million in 2025.
  • Its Loans - Loss Allowance stands at $100.3 million for Q4 2025, versus $101.8 million for Q3 2025 and $107.1 million for Q2 2025.